DHX34 and myelodysplastic syndrome: We previously identified heterozygous germline variants in DHX34 in four families affected of inherited acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) and showed that all these variants abrogated DHX34 NMD activity (Rio-Machin et al. 2020).